Clinical Trials Browser

Phase 3 × Morphine × Clear all

NCT03823534 2026-04-22

Post-Op Pain Control for Prophylactic Intramedullary Nailing.

Phase 3 Recruiting

LymphoidPlasma cell

Lymphoma, Multiple Myeloma, Pain, Pain, Postoperative

NCT04188418 2026-02-19

Fentanyl Buccal Tablet or Morphine for Exertional Dyspnea in Cancer Patients

Phase 3 Active not recruiting

Other hematologic neoplasm

Hematologic Neoplasms

NCT06349668 2026-02-05

SMILe

Phase 3 Recruiting

Kidney Neoplasms, Ureteral Neoplasms, Vesico-Ureteral Reflux, Nephrolithiasis

NCT06940570 2025-10-23

MATCH

Phase 3 Suspended

Classical hematologyOtherOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Aplastic, Leukemia, Neoplasms, Pain, Intractable, Mucositis

NCT05236647 2025-03-06

SIM

Phase 3 Completed

Cancer Pain

NCT05325164 2022-12-05

METHADOPT

Phase 3 Withdrawn

Cancer Pain, Adenocarcinoma, Neoplasms

NCT03825887 2021-08-02

PCA

Phase 3 Completed

Other hematologic neoplasm

Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute

NCT01318161 2021-02-16

EPICOL

Phase 3 Terminated

Gastrointestinal

Pain, Colorectal Neoplasms

NCT00003687 2020-04-03

Treatment for Chronic Pain in Patients With Advanced Cancer

Phase 3 Completed

DermatologicLymphoidMyeloidOther hematologic neoplasmOther neoplasmPlasma cell

Pdgfra-Associated Chronic Eosinophilic Leukemia, Immunoglobulin Light-chain Amyloidosis, Blast Crisis, Burkitt Lymphoma, Hodgkin Disease, Immunoblastic Lymphadenopathy, Leukemia, Leukemia, Hairy Cell, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Mycosis Fungoides, Myelodysplastic Syndromes, Myeloproliferative Disorders, Pain, Polycythemia Vera, Precancerous Conditions, Sezary Syndrome, Thrombocythemia, Essential, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Biphenotypic, Acute, Leukemia, Prolymphocytic, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Neutrophilic, Chronic, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Leukemia, Large Granular Lymphocytic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Primary Myelofibrosis

NCT00505414 2019-11-01

A Study to Evaluate the Effectiveness and Safety of CG5503 (Tapentadol) in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine

Phase 3 Terminated

136 enrolled 9 charts

Neoplasms, Pain

NCT02591017 2018-11-13

ONKEMI

Phase 3 Terminated

Cancer: Breakthrough Pain

NCT01675622 2018-05-21

Immediate-Release Oxycodone Capsules Study in Cancer Pain

Phase 3 Completed

242 enrolled 20 charts

Cancer Pain, Neoplasms

NCT02687347 2016-09-20

UDOME

Phase 3 Unknown

Pain, Intractable

NCT00634010 2016-05-09

Morphine Versus Methadone As First Line Strong Opioid for Cancer Pain

Phase 3 Terminated

36 enrolled 6 charts

Cancer Pain

NCT00201539 2015-04-08

Double Bedtime Dosing During Immediate-release Morphine Administration to Cancer Patients

Phase 3 Completed

Neoplasms

NCT01825993 2013-04-08

2013/004

Phase 3 Unknown

Sigmoidal Tumour

NCT01309386 2013-03-13

A Safety and Efficacy Study of Oral Tapentadol Extended-Release in Japanese Participants

Phase 3 Completed

100 enrolled 12 charts

Cancer Pain, Neoplasms

NCT01367418 2012-03-19

AIMS

Phase 3 Completed

Inflammation, Prostatic Neoplasms

NCT00410540 2010-04-27

A Study of OROS Hydromorphone HCL vs Morphine in Cancer Pain Patients.

Phase 3 Completed

Cancer Pain, Pain

NCT00822614 2009-01-14

FINDS

Phase 3 Unknown

Pain